جست‌وجوی استاد و پژوهشگر

Shinjini Kunduمشاهده پروفایل

استادیار

• Artificial Intelligence
• Machine Learning
• Bioinformatics
• +۵ مورد دیگر

Shinjini Kundu is an Assistant Professor with joint appointments in Radiology and Electrical & System Engineering. She is affiliated with the Section of Neuroradiology and the Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS), specifically contributing to the Biomedical Informatics and Data Science, Computational and Systems Biology, and Neurosciences programs. Her research integrates: Artificial Intelligence and Machine Learning for medical applications Neuroimaging and Computer Vision techniques Bioinformatics approaches to brain disorders Explainable AI frameworks for clinical trustworthiness Her recent publications focus on neurodegenerative disease detection, brain-behavior relationships in autism, cortical mapping via unsupervised learning, and ethical AI in medicine. Research demonstrates consistent emphasis on MRI innovation, machine learning scalability, and clinical neuroscience applications. Dr. Kundu actively mentors PhD students and has generated significant academic impact with 847 citations. Her work has been featured in 46+ news outlets and referenced in policy documents.

William Hennahمشاهده پروفایل

مدرس

• Genetics
• Neuroscience
• Psychiatric Genetics
• +۳ مورد دیگر

William Hennah is a Lecturer Supervisor in the Doctoral Programme at the University of Helsinki, working within the Neuroscience Research Center and the Doctoral Programme Brain & Mind. His research focuses on the genetic basis of neurological and psychiatric disorders, particularly schizophrenia and related mental illnesses, with extensive use of Finnish population cohorts. His research interests include: Genetics of mental illness, particularly schizophrenia Neuroscience and brain function Genome-wide association studies (GWAS) Gene regulation in psychiatric disorders Neurodevelopmental aspects of mental illness DISC1 gene pathway research Hennah's recent publications demonstrate a sophisticated approach to genetic research, spanning from traditional psychiatric genetics to novel applications in respiratory medicine, pain research, and endocrinology. His work consistently leverages the unique genetic structure of the Finnish population for powerful genetic studies. His significant contributions include: Development of bioinformatics tools like DeepPheWAS for phenome-wide association studies Extensive investigations into the DISC1 gene pathway and its role in mental illness Studies on gene expression changes related to immune processes in schizophrenia Research on the NDE1/miR-484 locus and its implications for mental illness Dr. Hennah has served as a dissertation supervisor, has been active in peer review for leading journals including Molecular Psychiatry and Schizophrenia Research, and has led multiple research projects focused on the genetics of schizophrenia and related disorders. His work bridges fundamental genetic research with clinical applications in psychiatry.

• Neuropsychiatric Disorders
• Developmental Neurobiology
• Serotonin Signaling
• +۳ مورد دیگر

Mark Ansorge , PhD, is Associate Professor of Clinical Neurobiology (in Psychiatry) at Columbia University's College of Physicians and Surgeons. His research investigates developmental origins of neuropsychiatric disorders through multi-disciplinary approaches integrating mouse genetics , pharmacogenetics , and optogenetics . Education : MS in Biochemistry (University of Potsdam, Germany), PhD in Neurobiology (Free University of Berlin, Germany), Postdoc (Columbia University, USA) Dr. Ansorge's work focuses on serotonin signaling during critical developmental windows and its long-term impacts on emotional and cognitive behaviors. His lab has demonstrated that early-life perturbations in 5-HT systems lead to persistent changes in raphe nuclei , hippocampus , and medial prefrontal cortex circuitry, linking these alterations to increased adult vulnerability for depression and anxiety disorders . Recent publications highlight his expanding scope into gut-brain axis interactions (2025) and adolescent dopamine transporter manipulation (2023). While primarily using mouse models , his work maintains translational relevance through collaborations with clinical researchers.

• PTSD
• TBI
• Biomarkers
• +۵ مورد دیگر

Dr. Lei Zhang serves as Associate Professor of Psychiatry and Neuroscience at the Uniformed Services University of the Health Sciences (USU) in Bethesda, MD, holding primary appointment in the Department of Psychiatry within the School of Medicine. His research focuses on molecular mechanisms underlying stress-related disorders in military populations, with emphasis on biomarker discovery for PTSD and TBI. Education: 1976: M.D. from Shanghai Medical University 1977-1980: Psychiatry residency at Shanghai Medical University 1992-2000: Senior Staff Fellow at National Institute of Mental Health (NIMH), NIH Dr. Zhang's research centers on molecular and cellular mechanisms of PTSD and TBI, investigating genes including p11 (S100A10), BDNF, and mitochondria-related pathways. His work demonstrates p11's role as a PTSD biomarker in peripheral blood, BDNF's association with suicidal ideation in service members, and FKBP5 genetic variants as PTSD risk factors. He examines telomere dynamics and stress response pathways through cross-species translational studies. Analysis of his 15 most recent publications (2008-2023) reveals consistent focus on military-relevant PTSD biomarkers, with increasing integration of multi-omics approaches. Key themes include glucocorticoid-mediated gene regulation, mitochondrial dysfunction in stress response, and genetic predictors of PTSD susceptibility. His work bridges rodent stress models with human military cohorts to identify diagnostic tools and therapeutic targets. No scientific awards were explicitly mentioned in the source material. Dr. Zhang leads collaborative research through the Biomarker Study Group and Traumatic Stress Brain Study Group, securing NIH and military funding for large-scale PTSD investigations in US service members. His mentorship is evidenced through co-authorship with junior researchers on translational projects, though specific students aren't listed. Current work focuses on chemokine biomarkers and mitochondrial pathways for PTSD diagnostics. His laboratory at USU maintains active collaborations with the National Capital Consortium, employing multidisciplinary teams of neuroscientists, geneticists, and military medical personnel to advance stress disorder research through integrated molecular, genetic, and clinical approaches.

Marian Tanofsky-Kraffمشاهده پروفایل

استاد

• Eating disorders
• obesity
• pediatric overweight
• +۵ مورد دیگر

Dr. Marian Tanofsky-Kraff is a Professor in the Departments of Medical and Clinical Psychology and Medicine at the Uniformed Services University of the Health Sciences. She serves as Vice Chair of Research, Director of the Developmental Research Laboratory on Eating and Weight Behaviors, and Research Director for the Military Cardiovascular Outcomes Research Program (MiCOR). She is also a Research Collaborator in the Section on Growth and Obesity at the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. Dr. Tanofsky-Kraff's educational background includes: Ph.D. in Clinical Psychology from Catholic University of America (2003), with emphasis on Pediatric Overweight and Disordered Eating Postdoctoral Fellowship at the National Institutes of Health (2003-2006) in the Unit on Growth and Obesity M.A. in Clinical Psychology from Catholic University of America (2000) Predoctoral Research Internship at Yale University (1992-1996) focusing on Eating and Weight Disorders B.A. in English from University of Rochester (1987) Her research program focuses on the intersection of obesity and eating disorders, particularly examining psychological factors that promote obesity in children and adolescents. She has developed assessment methods for endophenotyping pediatric eating patterns and has conducted intervention trials aimed at preventing adult obesity and eating disorders. Her work has significant implications for military health, given her focus on military-dependent populations. Dr. Tanofsky-Kraff's extensive publication record demonstrates consistent focus on loss-of-control eating, cardiometabolic health, and interventions for weight management in youth. Her recent work has particularly emphasized military-dependent populations and the intersection of mental health with eating behaviors. Dr. Tanofsky-Kraff has received numerous scientific awards and recognitions: The Obesity Society Lilly Scientific Achievement Award (2016) Uniformed Services University Hébert Impact Award (2019) Fellow of The Obesity Society Fellow and Past Board Member of the Academy for Eating Disorders Past President and Board Member of the Eating Disorders Research Society As a mentor, Dr. Tanofsky-Kraff has guided numerous students and received multiple awards for her mentorship, including several Mentors Awards of the Board of Regents and The Obesity Society's awards. She serves as a mentor for over 15 training grants and has received research funding from several NIH institutes. Her laboratory, the Developmental Research Laboratory on Eating and Weight Behaviors, conducts cutting-edge research on pediatric eating patterns and their relationship to obesity and eating disorders.

• Neuropsychiatry
• Inhibitory Processing Deficits
• Bipolar Disorder
• +۵ مورد دیگر

Dr. William Perry is a leading neuropsychologist and academic at UC San Diego's Department of Psychiatry, holding multiple leadership positions including Vice Chair for Program Development & Operations, Co-Director of Clinical Psychiatry, and Chief Supervising Psychologist at UCSD Medical Center. He serves as Executive Director of the National Academy of Neuropsychology and is a Fellow of both NAN and the Society for Personality Assessment. His research program focuses on inhibitory processing deficits in neuropsychiatric conditions using innovative methods: Psychophysiological assessment of unmedicated psychiatric patients Longitudinal studies of information processing deficits Translational approaches bridging human and animal models Computational analysis of behavioral dynamics Major research domains include: Bipolar disorder pathophysiology Schizophrenia neurocognition Substance use comorbidities Neurocognitive impacts of HIV and HCV Endocannabinoid system functions Recent publications (2018-2025) demonstrate strong research output in: Neuropsychopharmacology of cannabis and stimulants Computational psychiatry approaches Cross-species validation of neuropsychiatric models Neurocognitive aspects of viral infections Sensorimotor processing deficits Dr. Perry has received significant scientific recognition: Fellow, National Academy of Neuropsychology Fellow, Society for Personality Assessment Principal Investigator on multiple NIH R01 grants spanning nearly 20 years He maintains active clinical programs in neuropsychological assessment and consultation-liaison psychiatry, with specialized services for pain management, transplantation, and burn patients.

Jin H. Yoonمشاهده پروفایل

دانشیار

• Addiction Research
• Substance Use Disorders
• Nicotine Dependence
• +۵ مورد دیگر

Jin H. Yoon, PhD is an Associate Professor in the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at The University of Texas Health Science Center at Houston. He is an active addiction researcher affiliated with the Center of Neurobehavioral Research on Addiction (CNRA), focusing primarily on nicotine dependence and substance use disorders. Dr. Yoon's research spans multiple domains within addiction science. His primary interest is on nicotine dependence, particularly among individuals with schizophrenia. He is currently the primary investigator in a clinical trial studying nicotine dependence in this population and potential nicotine-replacement therapy approaches. Beyond this specific focus, Dr. Yoon is interested in developing both behavioral and drug treatments for substance use disorders, exploring mechanisms related to substance use such as impulsivity, and utilizing novel technologies to advance research in the field. His scholarly output includes over 60 publications and numerous national and international presentations. Analyzing his recent work reveals a strong emphasis on clinical applications, with particular attention to comorbid conditions, technological innovations in assessment and treatment, and mechanistic studies of addiction processes. His research increasingly incorporates digital health approaches alongside traditional clinical methodologies. Over 60 peer-reviewed publications in addiction science Extensive national and international presentation record Current primary investigator on clinical trials for nicotine dependence in schizophrenia Dr. Yoon completed his PhD in experimental analysis of behavior at the University of Florida followed by a postdoctoral fellowship at the University of Vermont. His training has equipped him to bridge basic behavioral science with clinical applications in addiction medicine. As an active researcher at CNRA, he continues to advance our understanding of substance use disorders and develop more effective treatments for affected individuals.

• Pediatric Traumatic Brain Injury
• Neuroimaging
• Neurocognitive Outcomes
• +۵ مورد دیگر

Talin Babikian is an Associate Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. With extensive expertise in pediatric traumatic brain injury (TBI) and neuroimaging, Dr. Babikian's research focuses on understanding neurocognitive outcomes, recovery trajectories, and the application of advanced neuroimaging techniques to assess brain structure and function following pediatric TBI. Dr. Babikian's research interests span multiple areas within pediatric neurotrauma, including neuroimaging techniques (particularly DTI and MRS), neurocognitive assessment following TBI, white matter integrity disruptions, long-term outcomes of pediatric concussion, and the impact of family environment on recovery. Her work frequently examines how brain injury affects developing neural systems and cognitive functioning in children and adolescents, with emphasis on translating research findings to clinical practice. Analysis of Dr. Babikian's recent publications reveals a strong focus on collaborative, large-scale research initiatives, particularly through the ENIGMA consortium. Her work increasingly addresses health disparities in concussion care, racial biases in sports-related concussion assessment, and the biopsychosocial factors influencing recovery. There's also a growing emphasis on multimodal approaches to understanding brain injury, combining neuroimaging, cognitive assessment, and clinical outcomes to develop more comprehensive models of TBI recovery. Dr. Babikian has been actively involved in significant research funding, most notably as Principal Investigator on the NIH-funded study "Neuroimaging and Recovery after Pediatric Brain Injury" (F32NS053169, 2006-2008). She is a key contributor to several major collaborative efforts including the UCLA RAPBI study, the ENIGMA Pediatric TBI working group, and the CARE4Kids study examining persistent post-concussive symptoms in adolescents. Her work has contributed substantially to our understanding of the neurobiological underpinnings of cognitive and emotional difficulties following pediatric TBI.

• Schizophrenia
• Cognitive Training
• Psychosis
• +۵ مورد دیگر

Keith H Nuechterlein is a Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He serves as Principal Investigator on multiple National Institutes of Health (NIH) funded research projects focused on schizophrenia and psychosis, including several R01 grants from the National Institute of Mental Health (NIMH). Dr. Nuechterlein's primary research interests center on cognitive impairments in schizophrenia, particularly in first-episode psychosis. His work investigates how cognitive training, aerobic exercise, and other interventions can improve cognitive function and real-world outcomes for individuals with schizophrenia. He has made significant contributions to understanding the relationship between cognitive deficits and functional outcomes, the development of cognitive assessment tools like the MATRICS Consensus Cognitive Battery, and the role of motivation in treatment engagement. His recent publications reveal a strong focus on innovative interventions for first-episode schizophrenia, with particular attention to the combination of cognitive training and aerobic exercise. His research employs diverse methodologies including clinical trials, neuroimaging, and analysis of genetic and physiological markers. A notable trend across his recent work is the examination of how intrinsic motivation influences treatment outcomes and the exploration of brain-body connections in schizophrenia pathophysiology. Dr. Nuechterlein has served as Principal Investigator on multiple major research grants totaling millions of dollars in funding, including the current R01 MH130848 ( Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode ) and R01 MH129351 ( Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis ). His research program has consistently focused on translating basic science findings into clinical interventions that improve functional outcomes for individuals with schizophrenia.

Joseph Buxbaumمشاهده پروفایل

استاد

• Autism Spectrum Disorder
• Alzheimer's Disease
• Schizophrenia
• +۷ مورد دیگر

Joseph Buxbaum serves as Professor of Psychiatry at Icahn School of Medicine at Mount Sinai and Director of the Seaver Autism Center for Research and Treatment. His academic appointments span multiple institutes including the Friedman Brain Institute, Genetics and Genomic Sciences, and the Mindich Child Health and Development Institute, reflecting his interdisciplinary research approach. Dr. Buxbaum's research focuses on the genetic and molecular mechanisms underlying neurodevelopmental and psychiatric disorders. His laboratory investigates autism spectrum disorder through genetic mapping and functional characterization of susceptibility genes like SHANK2 and AGC1. In schizophrenia research, his team pioneered the oligodendrocyte dysfunction hypothesis based on microarray studies. For Alzheimer's disease, they examine amyloid precursor protein signaling pathways and calsenin function in amyloid processing. His publication record demonstrates sustained productivity with 493 research outputs including over 400 articles. Recent work shows continued high output with 16 publications in 2023 and multiple 2024-2025 publications in high-impact journals. Analysis of his recent articles reveals strong emphasis on genomic approaches to autism, OCD, and dementia, with particular focus on rare variants, cross-disorder analyses, and functional validation. Dr. Buxbaum's scientific impact is evidenced by his h-index of 132 and 85,766 citations. While specific awards aren't listed in the source material, his leadership of the Seaver Autism Center and participation in major genomic consortia indicate significant recognition in the field. As director of the Laboratory of Molecular Neuropsychiatry, he mentors trainees in molecular analysis of neurological diseases using state-of-the-art techniques. His lab maintains active collaborations through the Trans-Ancestry OCD Genomics Initiative, Alzheimer's Disease Genetics Consortium, and international autism research networks. Current research leverages genomic sequencing, animal models, and stem cell technologies to advance understanding of neurodevelopmental disorders.

• Neuroscience
• Psychiatry
• Mood Disorders
• +۴ مورد دیگر

Julian Macoveanu serves as a Guest Researcher at the Department of Psychology within the Faculty of Social Sciences at the University of Copenhagen. His research program focuses on the neural mechanisms underlying mood disorders, particularly examining brain structure-function relationships in bipolar disorder and major depressive disorder using advanced neuroimaging techniques. Dr. Macoveanu's research interests span clinical neuroscience with emphasis on: Neural correlates of cognitive impairment in mood disorders Brain structural and functional changes associated with psychiatric conditions Neural predictors of treatment response to interventions like electroconvulsive therapy Emotion regulation processes in bipolar disorder Longitudinal brain changes in psychiatric populations and their relatives His recent publication record demonstrates a cohesive research trajectory investigating how specific brain regions (particularly amygdala and hippocampal structures) relate to clinical symptoms and treatment outcomes. Dr. Macoveanu employs sophisticated fMRI methodologies to examine both structural and functional neural characteristics across multiple patient populations. Dr. Macoveanu maintains an active research profile with multiple publications appearing in high-impact psychiatric journals including Journal of Affective Disorders, Bipolar Disorders, and Acta Psychiatrica Scandinavica. His work frequently appears with significant social media engagement and academic readership as indicated by X (Twitter) mentions and Mendeley reader counts. His research collaborations extend across multiple departments at the University of Copenhagen, particularly working with clinical psychiatry researchers to bridge neuroimaging findings with clinical applications. Dr. Macoveanu's work contributes to the growing understanding of neural biomarkers that could potentially inform more personalized treatment approaches for mood disorders.

• Epidemiology
• Medical Genetics
• Genomics
• +۵ مورد دیگر

Patrick Magnusson is a Senior Researcher and Associate Professor of Epidemiology at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics. Since 2014, he has served as head of the Swedish Twin Registry (STR), overseeing operations and administration while establishing a comprehensive biobank with DNA samples from participating twins. His educational background includes a Master of Medical Sciences (1996) and Doctor of Medical Sciences (2000) from Uppsala University, followed by postdoctoral studies at Columbia University in New York (2000-2002). His thesis focused on genetic susceptibility to cervical and stomach cancers. Dr. Magnusson's research spans epidemiology, medical genetics, and genomics, with particular emphasis on understanding how genetic predispositions interact with environmental factors to influence health outcomes. His work leverages twin studies to disentangle hereditary and environmental contributions to complex diseases. He regularly teaches in medical, psychology, and doctoral programs at Karolinska Institutet. His extensive publication record demonstrates expertise across multiple domains including cancer epidemiology, psychiatric genetics, cardiovascular research, and environmental health. His most recent work features large-scale meta-analyses and trans-ancestry studies examining genetic factors in depression, heart disease, obesity-related conditions, and autoimmune disorders. Dr. Magnusson actively contributes to major international research consortia, frequently collaborating across disciplines and institutions to advance understanding of complex disease etiology through innovative epidemiological and genetic approaches.